It may be niche, but it's a big niche in a data-driven world.

Flash floods are among the deadliest weather events in the world, killing more than 5,000 people each year. They’re also among the most difficult to predict. But Google thinks it has cracked that ...

Co-Founded by Nobel Prize Laureate, Alain Aspect, with deep bench of scientific leaders and intellectual property Pure play neutral atom quantum computing company with 7 quantum computers deployed ...

PARIS & NEW YORK--(BUSINESS WIRE)--Pasqal Holding SAS (“Pasqal”), a global leader in neutral atom quantum computing, and Bleichroeder Acquisition Corp. II (“Bleichroeder”), a SPAC led and backed by ...

Pasqal Holding SAS (“Pasqal”), a global leader in neutral atom quantum computing, and Bleichroeder Acquisition Corp. II (“Bleichroeder”), a SPAC led and backed by Michel Combes and Andrew Gundlach ...

Michel Combes and Andrew Gundlach, Co-Sponsors of Bleichroeder Acquisition Corp. II, commented: "Pasqal represents the strength of French scientific excellence translated into commercial leadership.

mCOMBRIAX is the world’s first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and represents Moderna’s fourth vaccine to receive a positive ...

Additional intellectual property protection reinforces the strategic value of IP-001 and supports ongoing clinical development efforts. SAINT LOUIS, MO, UNITED STATES ...

In patients with HIV infection, the use of opioids alone was not associated with reduced cognition or depressive mood, whereas the combined use of opioids, antidepressants, and statins or ...

What Is It, and Why Does It Matter? Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in ...

Institutional investors are factoring quantum computing risk into Bitcoin allocations, not dismissing it as distant. Research suggests millions of BTC could be vulnerable due to reused keys and legacy ...

Rybrevant Faspro is a new under-the-skin (subcutaneous) injection form of the cancer medicine Rybrevant (amivantamab). The FDA has now approved it in combination with another medicine called ...